Announcements
- Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
- Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
- Harvard Bioscience Announces First Quarter 2024 Financial Results
- Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
- Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
- Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
- Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.68 |
---|---|
High | 2.68 |
Low | 2.68 |
Bid | 2.68 |
Offer | 2.74 |
Previous close | 2.76 |
Average volume | 0.00 |
---|---|
Shares outstanding | 43.43m |
Free float | 40.07m |
P/E (TTM) | -- |
Market cap | 135.93m USD |
EPS (TTM) | -0.2029 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 07:18 BST.
More ▼